A retrospective clinical follow-up analysis of 32 patients with bilomas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015208

Enrollment

Registered

2018-08-06

Start date

2017-04-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K83

Interventions

Group 1: No groups, clinical follow-up with spectrum of pathogens, therapies and outcome of patients with biloma treated in the Klinikum rechts der Isar between 2004 and 2015.

Eligibility

Sex/Gender

All

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: •Presentation of a bile fluid collection after injection of contrast agent into the biliary system via ERC/PTCD •Typical medical history like ERC, TACE, hepatobiliary surgery, photodynamic therapy or liver transplantation. Retrospective inclusion of patients with biloma treated between 2004 to 2015 in the Klinikum rechts der Isar

Exclusion criteria

Exclusion criteria: Incomplete patient records

Design outcomes

Primary

Measure	Time frame
Aim of this study is to describe symptoms, therapie options and outcome of bilomas	—

Countries

Germany

Contacts

Public ContactJochen Schneider

Klinikum rechts der Isar, TU München

Jochen.Schneider@tum.de0049-89-4140-9369

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 3, 2026